GI
TNDM icon

Gradient Investments’s Tandem Diabetes Care TNDM Stock Holding History

Gradient Investments’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-400
Closed -$2K – 1137
2018
Q1 		$2K Hold
400
– – ﹤0.01% 844
2017
Q4 		$1K Buy
+400
New +$1.26K ﹤0.01% 957
2017
Q3 		– Sell
-400
Closed -$3K – 667
2017
Q2 		$3K Sell
400
-12,842
-97% -$119K ﹤0.01% 659
2017
Q1 		$159K Sell
13,242
-878
-6% -$19.2K 0.01% 231
2016
Q4 		$304K Buy
14,120
+9,861
+232% +$379K 0.03% 157
2016
Q3 		$326K Buy
+4,259
New +$311K 0.03% 153

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Gradient Investments's TNDM Position: Q2 2018 in Review

Gradient Investments sold out of Tandem Diabetes Care (TNDM) in Q2 2018, closing a stake of 400 shares — an estimated $2K sold.

Gradient Investments first reported a position in TNDM in Q3 2016 and held it in 6 quarters. The position peaked at $326K in Q3 2016. 116 funds tracked by Wall St. Rank hold TNDM as of Q2 2018.

  • Gradient Investments reported no remaining Tandem Diabetes Care position as of Q2 2018 after selling out during the quarter.
  • Gradient Investments sold 400 Tandem Diabetes Care shares in Q2 2018, an estimated $2K.
  • Gradient Investments first reported a position in Tandem Diabetes Care in Q3 2016 and held it in 6 quarters.
  • Gradient Investments's Tandem Diabetes Care position peaked at $326K in Q3 2016.
  • 116 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2018.

Based on Gradient Investments's 13F filing for Q2 2018, filed 9 Aug 2018.